Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Am J Kidney Dis. 2021 Mar 30;78(4):550–559.e1. doi: 10.1053/j.ajkd.2021.01.017

Table 1.

Patient characteristics (N=128)

Variable Value
Demographics
 Age, y 58.2 ± 14.4
 Male sex 91 (71.1%)
 Weight, kg 84.2 ± 23.2
 Height, cm 169.1 ± 10.1
 BMI. kg/m> 29.6 ± 7.8
Comorbtdites
 Hypertension 67 (52.3%)
 Diabetes 52 140.6%)
 CKD stages 1 –4 32 (25.0%)
 Kidney failure 22 (16.6%)
 CHF 43 (33.6%)
 Liver disease 32 (25.0%)
 Cancer 18 (14.1%)
Main clinical diagnosis at CKRT initiation
 Sepsis 46 (36.9%)
 Shock other than sepsis 43 (33.6%)
 Cardiovascular disease 38 (29.7%)
 Urinary calculus 1 (0.8%)
Disease severity
 SOFA score at dialysis start 14.9 ± 3.3
Laboratory data at CKRT initiation
 Serum urea nitrogen, mg/dL 55.5 ± 41.3
 Creatinine, mg/dL 3.6 ± 2.5
 pH 7.3 ± 0.1
Patient outcomes
 CKRT duration, d 5.7 [2.9–12.5]
 Hospital length of stay, d 27.0 [12.5–43.5]
 ICU length of stay, d 13.0 [8.0–22.5]
 ICU mortality 56 (42.9%)
 In-hospital mortality 65 (50.8%)

Values for continuous variables presented as mean ± SD or median [interquartile range]; categorical variables, as counts (percentage). Abbreviations: BMI, body mass index; CHF, congestive heart falure: CKO, chronic kidney disease; CKRT, continuous kidney replacement therapy; ICU, intensve care unit; SOFA, Sequential Organ Failure Assessment.